133 related articles for article (PubMed ID: 10619962)
1. Inositol hexakisphosphate in urine: the relationship between oral intake and urinary excretion.
Grases F; Simonet BM; March JG; Prieto RM
BJU Int; 2000 Jan; 85(1):138-42. PubMed ID: 10619962
[TBL] [Abstract][Full Text] [Related]
2. Intake of myo-inositol hexaphosphate and urinary excretion of inositol phosphates in Wistar rats: Gavage vs. oral administration with sugar.
Grases F; Costa-Bauzá A; Berga F; Gomila RM; Martorell G; Martínez-Cignoni MR
PLoS One; 2019; 14(10):e0223959. PubMed ID: 31626632
[TBL] [Abstract][Full Text] [Related]
3. Influence of concomitant food intake on the excretion of orally administered myo-inositol hexaphosphate in humans.
Grases F; Costa-Bauza A; Perelló J; Isern B; Vucenik I; Valiente M; Muñoz JA; Prieto RM
J Med Food; 2006; 9(1):72-6. PubMed ID: 16579731
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of inositol phosphates in urine after topical administration of myo-inositol hexaphosphate to female Wistar rats.
Grases F; Costa-Bauzá A; Berga F; Rodríguez A; Gomila RM; Martorell G; Martínez-Cignoni MR
Life Sci; 2018 Jan; 192():33-37. PubMed ID: 29155299
[TBL] [Abstract][Full Text] [Related]
5. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.
Grases F; Perelló J; Prieto RM; Simonet BM; Torres JJ
Life Sci; 2004 May; 75(1):11-9. PubMed ID: 15102518
[TBL] [Abstract][Full Text] [Related]
6. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin in humans.
Grases F; Isern B; Perelló J; Sanchis P; Prieto RM; Costa-Bauzà A
Pharmazie; 2006 Jul; 61(7):652. PubMed ID: 16889078
[TBL] [Abstract][Full Text] [Related]
7. Intracellular and extracellular myo-inositol hexakisphosphate (InsP6), from rats to humans.
Grases F; Costa-Bauza A; Prieto RM
Anticancer Res; 2005; 25(3c):2593-7. PubMed ID: 16080499
[TBL] [Abstract][Full Text] [Related]
8. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats.
Grases F; Sanchis P; Perello J; Isern B; Prieto RM; Fernandez-Palomeque C; Fiol M; Bonnin O; Torres JJ
Front Biosci; 2006 Jan; 11():136-42. PubMed ID: 16146720
[TBL] [Abstract][Full Text] [Related]
9. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption.
Grases F; Isern B; Perelló J; Sanchis P; Prieto RM
Front Biosci; 2005 Jan; 10():799-802. PubMed ID: 15569619
[TBL] [Abstract][Full Text] [Related]
10. Study of the absorption of myo-inositol hexakisphosphate (InsP6) through the skin.
Grases F; Perelló J; Isern B; Prieto RM
Biol Pharm Bull; 2005 Apr; 28(4):764-7. PubMed ID: 15802828
[TBL] [Abstract][Full Text] [Related]
11. Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications.
Grases F; Costa-Bauza A
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817119
[TBL] [Abstract][Full Text] [Related]
12. Phytate levels in diverse rat tissues: influence of dietary phytate.
Grases F; Simonet BM; Prieto RM; March JG
Br J Nutr; 2001 Aug; 86(2):225-31. PubMed ID: 11502236
[TBL] [Abstract][Full Text] [Related]
13. Inositol hexakisphosphate binding sites in rat heart and brain.
Rowley KG; Gundlach AL; Cincotta M; Louis WJ
Br J Pharmacol; 1996 Aug; 118(7):1615-20. PubMed ID: 8842422
[TBL] [Abstract][Full Text] [Related]
14. Do mammals make all their own inositol hexakisphosphate?
Letcher AJ; Schell MJ; Irvine RF
Biochem J; 2008 Dec; 416(2):263-70. PubMed ID: 18684107
[TBL] [Abstract][Full Text] [Related]
15. Inositol hexakisphosphate (phytic acid) enhances Ca2+ influx and D-[3H]aspartate release in cultured cerebellar neurons.
Nicoletti F; Bruno V; Fiore L; Cavallaro S; Canonico PL
J Neurochem; 1989 Oct; 53(4):1026-30. PubMed ID: 2769253
[TBL] [Abstract][Full Text] [Related]
16. Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion.
Prieto RM; Fiol M; Perello J; Estruch R; Ros E; Sanchis P; Grases F
Eur J Nutr; 2010 Sep; 49(6):321-6. PubMed ID: 20108098
[TBL] [Abstract][Full Text] [Related]
17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
18. There is no 'Conundrum' of InsP6.
Irvine RF; Bulley SJ; Wilson MS; Saiardi A
Open Biol; 2015 Nov; 5(11):. PubMed ID: 26581573
[TBL] [Abstract][Full Text] [Related]
19. Effect of Phytate (InsP6) and Other Inositol-Phosphates (InsP5, InsP4, InsP3, InsP2) on Crystallization of Calcium Oxalate, Brushite, and Hydroxyapatite.
Calvó P; Costa-Bauza A; Grases F
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509097
[TBL] [Abstract][Full Text] [Related]
20. Dietary phytate and mineral bioavailability.
Grases F; Simonet BM; Prieto RM; March JG
J Trace Elem Med Biol; 2001; 15(4):221-8. PubMed ID: 11846011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
